Recherche - Archive ouverte HAL Accéder directement au contenu

Filtrer vos résultats

19 Résultats
Auteur : personID (entier) : 761755
Image document

The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancer

Delphine Le Corre , Alexandre Ghazi , Ralyath Balogoun , Camilla Pilati , Thomas Aparicio et al.
EBioMedicine, 2019, 46, pp.94-104. ⟨10.1016/j.ebiom.2019.07.036⟩
Article dans une revue hal-02305551v1
Image document

Should we screen for colorectal cancer in people aged 75 and over? A systematic review - collaborative work of the French geriatric oncology society (SOFOG) and the French federation of digestive oncology (FFCD)

Lydia Guittet , Valérie Quipourt , Thomas Aparicio , Elisabeth Carola , Jean-François Seitz et al.
BMC Cancer, 2023, 23 (1), pp.17. ⟨10.1186/s12885-022-10418-5⟩
Article dans une revue hal-03972097v1
Image document

Prognostic value of the PrPC-ILK-IDO1 axis in the mesenchymal colorectal cancer subtype

Alexandre Ghazi , Delphine Le Corre , Camilla Pilati , Julien Taieb , Thomas Aparicio et al.
OncoImmunology, 2021, 10 (1), pp.1940674. ⟨10.1080/2162402x.2021.1940674⟩
Article dans une revue hal-03285118v1
Image document

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).

Astrid Lièvre , Anthony Turpin , Isabelle Ray-Coquard , Karine Le Malicot , Juliette Thariat et al.
European Journal of Cancer, 2020, 141, pp.62-81. ⟨10.1016/j.ejca.2020.09.035⟩
Article dans une revue hal-02998283v1

SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer

Emeric Boisteau , Eric François , Thomas Aparicio , Karine Le Malicot , Rabia Boulahssass et al.
Digestive and Liver Disease, 2022, 54 (6), pp.747-754. ⟨10.1016/j.dld.2022.03.001⟩
Article dans une revue hal-03632563v1

PRODIGE 34-FFCD 1402-ADAGE: Adjuvant chemotherapy in elderly patients with resected stage III colon cancer: A randomized phase 3 trial.

Thomas Aparicio , Eric Francois , Laurence Cristol-Dalstein , Elisabeth Carola , Emilie Maillard et al.
Digestive and Liver Disease, 2016, 48 (2), pp.206-7. ⟨10.1016/j.dld.2015.11.023⟩
Article dans une revue hal-01437519v1

Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: a French randomised double-blind phase III trial (PRODIGE 50-ASPIK)

Pierre Michel , Valérie Boige , Thierry André , Thomas Aparicio , Jean Baptiste Bachet et al.
Digestive and Liver Disease, 2018, 50 (3), pp.305-307. ⟨10.1016/j.dld.2017.12.023⟩
Article dans une revue hal-01704109v1

Hepatocellular carcinoma: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, AFEF, SIAD, SFR/FRI)

Jean Frédéric Blanc , Audrey Debaillon-Vesque , Gaël Roth , Jean Claude Barbare , Anne Sophie Baumann et al.
Clinics and Research in Hepatology and Gastroenterology, 2021, 45 (2), pp.101590. ⟨10.1016/j.clinre.2020.101590⟩
Article dans une revue hal-03612929v1

Phase III randomized trial comparing 5-fluorouracil and oxaliplatin with or without docetaxel in first-line advanced gastric cancer chemotherapy (GASTFOX study)

Aziz Zaanan , Emmanuelle Samalin , Thomas Aparicio , Olivier Bouché , Pierre Laurent-Puig et al.
Digestive and Liver Disease, 2018, 50 (4), pp.408 - 410. ⟨10.1016/j.dld.2018.01.119⟩
Article dans une revue hal-01917535v1
Image document

COVID-19 epidemic Proposed alternatives in the management of digestive cancers A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)

Frédéric Di Fiore , Olivier Bouché , Come Lepage , David Sefrioui , Alice Gangloff et al.
Digestive and Liver Disease, 2020, 52 (6), pp.597-603. ⟨10.1016/j.dld.2020.03.031⟩
Article dans une revue hal-02862261v1

Ipilimumab with atezolizumab-bevacizumab in patients with advanced hepatocellular carcinoma: The PRODIGE 81-FFCD 2101-TRIPLET-HCC trial

Philippe Merle , Jean-Frédéric Blanc , Julien Edeline , Karine Le Malicot , Manon Allaire et al.
Digestive and Liver Disease, 2023, ⟨10.1016/j.dld.2023.01.161⟩
Article dans une revue hal-04016442v1

Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)

Christophe Locher , Blaise Batumona , Pauline Afchain , Nicolas Carrère , Emmanuelle Samalin et al.
Digestive and Liver Disease, 2018, 50 (1), pp.15 - 19. ⟨10.1016/j.dld.2017.09.123⟩
Article dans une revue hal-01708040v1

PRODIGE 34-FFCD 1402-ADAGE Adjuvant chemotherapy in elderly patients ă with resected stage III colon cancer: A randomized phase 3 trial

Thomas Aparicio , Eric Francois , Laurence Cristol-Dalstein , Elisabeth Carola , Emilie Maillard et al.
Digestive and Liver Disease, 2016, 48 (2), pp.206-207
Article dans une revue hal-01482514v1
Image document

Impact of time-varying cumulative bevacizumab exposures on survival: re-analysis of data from randomized clinical trial in patients with metastatic colo-rectal cancer

Adrien Guilloteau , Michal Abrahamowicz , Olayide Boussari , Valérie Jooste , Thomas Aparicio et al.
BMC Medical Research Methodology, 2021, 21 (1), pp.14. ⟨10.1186/s12874-020-01202-9⟩
Article dans une revue inserm-03314999v1
Image document

PRODIGE 59-DURIGAST trial: A randomised phase II study evaluating FOLFIRI + Durvalumab ± Tremelimumab in second-line of patients with advanced gastric cancer

Camille Evrard , Christophe Louvet , Farid El Hajbi , Frédéric Di Fiore , Karine Le Malicot et al.
Digestive and Liver Disease, 2021, 53 (4), pp.420-426. ⟨10.1016/j.dld.2020.11.036⟩
Article dans une revue hal-03102304v1
Image document

Management of digestive cancers during the COVID-19 second wave: A French intergroup point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR)

David Tougeron , Pierre Michel , Astrid Lièvre , Michel Ducreux , Sébastien Gaujoux et al.
Digestive and Liver Disease, 2021, 53 (3), pp.306-308. ⟨10.1016/j.dld.2020.11.029⟩
Article dans une revue hal-03102287v1

Aflibercept in Combination With FOLFIRI as First-line Chemotherapy in Patients With Metastatic Colorectal Cancer (mCRC): A Phase II Study (FFCD 1302)

Alexandra Lapeyre-Prost , Simon Pernot , Julie Sigrand , Karine Le Malicot , Florence Mary et al.
Clinical Colorectal Cancer, 2020, 19 (4), pp.285-290. ⟨10.1016/j.clcc.2020.06.003⟩
Article dans une revue hal-03284418v1

Baseline Splenic Volume as a Prognostic Biomarker of FOLFIRI Efficacy and a Surrogate Marker of MDSC Accumulation in Metastatic Colorectal Carcinoma

Julie Niogret , Emeric Limagne , Marion Thibaudin , Julie Blanc , Aurelie Bertaut et al.
Cancers, 2020, 12 (6), pp.1429. ⟨10.3390/cancers12061429⟩
Article dans une revue hal-03284403v1

Treatment of advanced hepatocellular carcinoma with long-acting octreotide: a phase III multicentre, randomised, double blind placebo-controlled study.

Jean-Claude Barbare , Olivier Bouché , Franck Bonnetain , Laetitia Dahan , Catherine Lombard-Bohas et al.
European Journal of Cancer, 2009, 45 (10), pp.1788-97. ⟨10.1016/j.ejca.2009.02.018⟩
Article dans une revue hal-00515746v1